“…25,26 His initial positive experiences with TSA for the management of glenohumeral osteoarthritis have been confirmed by numerous clinical studies reporting significant improvements in pain and function. 8,[15][16][17]19,34 Despite the highly satisfactory clinical outcomes and low reported complication rates, glenoid loosening and revision for glenoid loosening remain the major issues concerning the longevity of TSA. The reported incidence of radiolucency at the boneecement interface is high, up to 30% to 90%, 4,7,27,34 the rate of radiologic loosening is between 0% and 44%, 29,40 and rates of glenoid revision for loosening are 8% to 10%.…”